Although the information on BTZ resistance in MCL is still very limited, certain characteristics of BTZ-resistant MCL have previously been reported, namely uncontrolled plasmacytic differentiation and activation of B-cell receptor (BCR) signaling [13,14]. This evidence concerns the gene BCR and mantle cell lymphoma.